Insider trades
Campbell David Alan, CEO of Janux Therapeutics JANX, has filed 0 purchases and 11 sales on the open market. Over the past 12 months that comes to a net sale of $110.8K. The latest trade was on 01/02.
Campbell David Alan
President and CEO
- Company
- Janux Therapeutics JANX
- First filing
- 23/01/05
- Trades
- 17 trades
- Buys / sales
- 0 / 11
- 12-month net buying
- −$110.8K
- Last trade
- 01/02
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 01/02 | 01/02 | 8,072 sh | $13.73 | $110,828.56 | −2.8% | |
| Open-market sale10b5-1 plan | 25/01/07 | 25/01/08 | 5,000 sh | $60.00 | $300,000 | −1.7% | |
| Open-market sale10b5-1 plan | 24/12/24 | 24/12/27 | 25,000 sh | $56.19 | $1,404,750 | −10.3% | |
| Open-market sale10b5-1 plan | 24/12/03 | 24/12/03 | 15,000 sh | $67.00 | $1,005,000 | −5.8% | |
JANX | Open-market sale10b5-1 plan | 24/11/25 | 24/11/27 | 25,000 sh2 trades | $51.59avg. | $1,289,848.59 | −8.9% |
JANX | Open-market sale10b5-1 plan | 24/10/28 | 24/10/30 | 25,000 sh2 trades | $53.54avg. | $1,338,494.16 | −8.1% |
JANX | Open-market sale10b5-1 plan | 24/09/27 | 24/09/27 | 25,000 sh3 trades | $46.31avg. | $1,157,682.21 | −7.5% |